Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BenevolentAI is creating and applying AI technologies to transform the way medicines are discovered, developed, tested and brought to market. The Company has developed the Benevolent Platform™ - a leading computational and experimental discovery platform used by BenevolentAI scientists to find new ways to treat disease and personalise drugs to patients. The Benevolent Platform™ focuses on four key areas of drug discovery ...
BenevolentAI is creating and applying AI technologies to transform the way medicines are discovered, developed, tested and brought to market. The Company has developed the Benevolent Platform™ - a leading computational and experimental discovery platform used by BenevolentAI scientists to find new ways to treat disease and personalise drugs to patients. The Benevolent Platform™ focuses on four key areas of drug discovery and development: Knowledge and Reasoning, Target Identification, Molecular Design and Precision Medicine.

List your booth number for exhibitions, ask us